SEC 13F Intelligence

Deerfield Management Company, L.P. / MIRM

Deerfield Management Company, L.P.’s Mirum Pharmaceuticals Inc Position

Does Deerfield Management Company, L.P. own Mirum Pharmaceuticals Inc (MIRM)? Not currently — the last reported position was 2.03M shares worth $49M in Q1 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$49M
Q1 2023
Shares
2.03M
% of Portfolio
+1.09%
Quarters Held
15
position exited

Position History MIRM

Reported value by quarter
Q3 ’19: $35MQ3 ’19Q4 ’19: $85MQ1 ’20: $48MQ1 ’20Q2 ’20: $67MQ3 ’20: $66MQ3 ’20Q4 ’20: $60MQ1 ’21: $68MQ1 ’21Q2 ’21: $60MQ3 ’21: $65MQ3 ’21Q4 ’21: $52MQ1 ’22: $72MQ1 ’22Q2 ’22: $63MQ3 ’22: $43MQ3 ’22Q4 ’22: $40MQ1 ’23: $49MQ1 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20232.03M$49M+1.09%
Q4 20222.03M$40M+0.82%
Q3 20222.03M$43M+0.85%
Q2 20223.24M$63M+1.30%
Q1 20223.28M$72M+1.62%
Q4 20213.28M$52M+1.10%
Q3 20213.28M$65M+1.28%
Q2 20213.45M$60M+1.06%
Q1 20213.45M$68M+1.44%
Q4 20203.45M$60M+1.19%
Q3 20203.45M$66M+1.62%
Q2 20203.45M$67M+1.95%
Q1 20203.45M$48M+1.53%
Q4 20193.45M$85M+2.70%
Q3 20193.45M$35M+1.41%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Deerfield Management Company, L.P.’s full portfolio or all institutional holders of MIRM.